We established and validated the feasibility of an MRI-based radiomics nomogram to differentiate between multiple myeloma (MM) and bone metastasis of breast cancer (BC). Regions of interest were drawn for the largest bone lesion per patient on T1- and T2-weighted images of patients with MM (n = 85) and BC (n = 70) from two institutions. The machine learning model with logistic regression resulted in the best performance for differentiating MM from BC with both sequences in the test cases. Our proposed clinical radiomics analysis shows promise in differentiating MM from bone metastasis of BC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords